TRAW Traws Pharma, Inc.

$0.56▲ +6.17% Healthcare Other
After hours $0.58▲ +2.34% Sep 11, 7:53 PM ET
Volume 84.4K Avg Volume (10D) 60.5K
Key Metrics & Fundamentals
Market Cap
$8.67M
P/E Ratio
2.0
Div Yield
–%
52W Range
0.43 - 3.27
% vs 50 MA
-2.42%
% vs 200 MA
-59.68%
RSI-14
48.5
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.39
Free Cash Flow
-$7.50M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.35M
COGS
–
Operating Exp
$3.18M
Operating Income
-$3.18M
EBIT
-$3.18M
Pretax Income
-$3.05M
Net Income
-$3.05M
EPS (Diluted)
-0.16
Price & Volume History
Loading chart…
Recent News
Traws Pharma shares rise after Q2 loss comes in better than expected
InvestorsHub · Aug 17, 2026 12:31 PM
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
GlobeNewswire · Aug 14, 2026 8:30 PM
Traws Pharma Says Updated Toxicology Data Being Developed on Influenza Prophylaxis Program
MT Newswires · Jun 22, 2026 12:23 PM
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
GlobeNewswire · Jun 22, 2026 11:00 AM
SpaceX initiated, Salesforce upgraded: Wall Street's top analyst calls
The Fly · Jun 18, 2026 1:35 PM
Top Premarket Decliners
MT Newswires · Jun 15, 2026 11:41 AM
Traws Pharma Delays Phase 2 Influenza Study After UK Regulatory Review; Shares Down Pre-Bell
MT Newswires · Jun 15, 2026 10:42 AM
Traws Pharma Shares Slide After UK Regulator Postpones Influenza Study
InvestorsHub · Jun 15, 2026 10:26 AM
Financial Overview - Income Statement Quarterly

See TRAW's money flow as a full page

Social Sentiment
Avg +0.80 · 2 posts
DDNewsTRAW - Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program
r/wallstreetbets · Jan 10, 2025
The post highlights a 'breakthrough' in a key area of the company's research, suggesting potential positive developments.
positive +0.60
NewsTradeDiscussionTRAW just got early stage positive results for a BIRD FLU treatment. It’s a one dose treatment.
r/wallstreetbets · Dec 23, 2024
Significant stock price increase and positive trial results strongly indicate bullish sentiment.
very_positive +1.00
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙